Perrigo Company Plc
pharmaceutical company
PRGO NYSE
ISIN IE00BGH1M568 SEC CIK 1585364 LEI 549300IFOQS6R1QLY196
Follow Perrigo
Weekly email: filings, results
Revenue, last quarter
$988.6M
−5.2% vs same quarter last year
Net income
−$27.5M
−466.7% vs same quarter last year
EPS, diluted
−$0.20
−500% vs same quarter last year
Operating cash flow
$96.2M
+86.1% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $4.3B | −$1.4B |
| FY24 | $4.4B | −$171.8M |
| FY23 | $4.7B | −$12.7M |
| FY22 | $4.5B | −$140.6M |
| FY21 | $4.1B | −$68.9M |
| FY20 | $4.1B | −$162.6M |
| FY19 | $3.9B | $146.1M |
| FY18 | $4.7B | $131M |
| FY17 | $4.9B | $119.6M |
| FY16 | $5.3B | −$4B |
| FY15 | $4.2B | $136.1M |
| FY14 | $3.9B | $232.8M |
| FY13 | $800K | $441.9M |
| FY12 | $3.2B | $401.6M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 35.1% | −26.4% | −33.5% |
| FY24 | 35.3% | 2.6% | −3.9% |
| FY23 | 36.1% | 3.3% | −0.3% |
| FY22 | 32.7% | 1.8% | −3.2% |
| FY21 | 34.2% | 9.9% | −1.7% |
| FY20 | 36.6% | 6.5% | −4% |
| FY19 | 37% | 4.5% | 3.8% |
| FY18 | 38.7% | 5% | 2.8% |
| FY17 | 40% | 12.1% | 2.4% |
| FY16 | 38.9% | −37.9% | −76% |
| FY15 | 38.9% | 15.9% | 3.2% |
| FY14 | 37.1% | 14.6% | 5.9% |
| FY13 | - | 84887.5% | 55237.5% |
| FY12 | 34.5% | 17.9% | 12.7% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $145.1M |
| FY24 | $244.6M |
| FY23 | $303.8M |
| FY22 | $210.9M |
| FY21 | $4.2M |
| FY20 | $465.8M |
| FY19 | $250.1M |
| FY18 | $490.4M |
| FY17 | $610.3M |
| FY16 | $548.7M |
| FY15 | $718.2M |
| FY14 | $461.4M |
| FY13 | $449.7M |
| FY12 | $393.2M |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY25 | $159.3M | - |
| FY24 | $152.5M | - |
| FY23 | $149.7M | - |
| FY22 | $142.4M | $0 |
| FY21 | $129.6M | $0 |
| FY20 | $123.9M | $164.2M |
| FY19 | $112.4M | $0 |
| FY18 | $104.9M | $400M |
| FY17 | $91.1M | $191.5M |
| FY16 | $83.2M | $0 |
| FY15 | $64.8M | $0 |
| FY14 | $46.1M | $0 |
| FY13 | $33M | $0 |
| FY12 | $29M | $8.2M |
- Perrigo
- Healthcare median
Show the numbers
| Year | Perrigo | Healthcare median |
|---|---|---|
| FY25 | −33.5% | −30.6% |
| FY24 | −3.9% | −47% |
| FY23 | −0.3% | −58% |
| FY22 | −3.2% | −80.4% |
| FY21 | −1.7% | −71.9% |
| FY20 | −4% | −62.2% |
| FY19 | 3.8% | −46.3% |
| FY18 | 2.8% | −49.6% |
| FY17 | 2.4% | −45.9% |
| FY16 | −76% | −36% |
| FY15 | 3.2% | −38.4% |
| FY14 | 5.9% | −35.5% |
| FY13 | 55237.5% | −37.1% |
| FY12 | 12.7% | −29.1% |